Answers are grounded in this paper and cite their sources.
Observational analysis highlights improved outcomes in rectal neuroendocrine tumors, suggesting future research directions.
This article comments on a recent study by Guo et al demonstrating that pretraction-assisted endoscopic submucosal dissection (p-ESD) significantly improves treatment outcomes for rectal neuroendocrine tumors. Compared to conventional endoscopic submucosal dissection, p-ESD offers advantages such as shorter dissection time, higher R0 resection rates, and reduced incidence of complications. While acknowledging these encouraging findings, this study highlights key directions for future development: Elucidating the specific mechanisms of pretraction, establishing the generalizability of p-ESD through prospective multicenter studies, and validating its oncological efficacy through long-term follow-up. Addressing these issues is crucial for the broader application and standardization of p-ESD in clinical practice.
No takes yet. Share an insight, caveat, or question.
Dai et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: